Virginia Society of Health-System Pharmacists

Call for Award Nominations

 

Each year, VSHP recognizes pharmacy practitioners that have demonstrated outstanding service to the pharmacy profession within Virginia. 

 

VSHP Annual Awards include:

VSHP Technician of the Year

VSHP New Practitioner of the Year 

VSHP Pharmacist of the Year 

VSHP Collaboration Award

Clinical Pharmacy Practice Achievement Award 

R.D. Anderson Distinguished Leadership Award

 

 

To nominate: https://www.surveymonkey.com/r/GJPXCZL

 

Additional details on award criteria and nomination process can be found at Annual Awards. 

 

The deadline for award nomination is Monday, October 6, 2025. Awards will be presented during the VSHP Fall Seminar, Friday, November 7, 2025.  

 

2025 VSHP Fall Seminar Poster/Abstract Submission:

·  Form: https://docs.google.com/forms/d/e/1FAIpQLScLKvdgKn9vgUQWXdTADCiJjtA8fbbPRHROm125F46QYzagGg/viewform?usp=dialog

·  Abstract submissions for Fall Seminar Posters are due Monday, September 22nd, 2025

2025 VSHP Fall Seminar Presentation/Pearl Submission for the General Session, CLF, and Tech Summit:

·  Form: https://docs.google.com/forms/d/e/1FAIpQLSfJumTyBrGLtMRLZKMb0-Y-vil6ShEbj1trDbi_yvoJi304tg/viewform?usp=dialog 

·  Presentation/pearl submissions for Fall Seminar due on Monday, August 18th, 2025

Hot Topics:

Ambulatory Care

Antimicrobial Updates

Anticoagulation Updates

Artificial Intelligence in Pharmacy Practice

Asthma Updates

Controlled Substance Stewardship

Critical Care/Emergency Medicine/Toxicology

Data Management

Diabetes Updates

Employee Engagement

GLP-1 Receptor Agonists

Heart Failure Updates

Informatics

Pediatrics/Neonatal

Retail and Specialty Pharmacy

Seizure Updates

Stroke Updates

Technician Advancement and Resume Building

USP 797/800

Women's and Men's Health

VSHP Webinar 

Recording 

Wednesday, June 25, 2025 – 12:00pm-1:00 pm

Metabolic Dysfunction Associated Steatotic Liver Disease in Patients with Diabetes

Speaker:

Keerthana Akkisetty, Pharm.D.
PGY2 Ambulatory Care Resident
VCU School of Pharmacy

Objectives for Pharmacists            

At the completion of this activity, the participant will be able to:

1. Discuss updated terminology for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

2. Apply screening and diagnosis tools for progression of MASLD

3. Recognize initiation and monitoring parameters for  pharmacotherapy in a person with MASLD

Objectives for Pharmacy Technicians      

At the completion of this activity, the participant will be able to:

1. Discuss updated terminology for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

2. List screening and diagnosis tools for progression of MASLD

Accreditation:

Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

ACPE UAN:  0108-0000-25-058-L01-P; 0108-0000-25-058-L01-T

Activity type: Knowledge-based

This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

Non-members will be charged $20.

To register: https://us06web.zoom.us/webinar/register/WN_I1BD-HBITxC90sFTzxZPLw

VSHP Webinar 

Recording

Thursday, June 19, 2025 – 12:00pm-1:00 pm

Stroke of Genius: Navigating the 2024 Guideline Update in Pharmacologic Prevention

Speaker:

Taylor Bernas, PharmD

Pharmacy Resident

Chesapeake Regional Medical Center

Objectives for Pharmacists            

At the completion of this activity, the participant will be able to:

• Identify key recommendation updates to the 2024 AHA/ASA Primary Prevention of Stroke guidelines.
• Describe major changes in lifestyle modification advice (diet, exercise, smoking cessation, sleep, etc.) and risk factor screening (e.g., blood pressure, diabetes, cholesterol, social determinants of health) for stroke prevention
• Identify updates in pharmacologic management for stroke prevention, including use of antihypertensives, statins and newer lipid-lowering agents, diabetes medications (e.g., GLP-1 agonists), and antithrombotic therapy
• Discuss stroke prevention considerations in special populations, such as women (pregnancy, menopause, etc.) and transgender patients, as introduced in the 2024 guidelines
• List diabetes medications that now carry guideline-recommended cardiovascular and stroke risk reduction benefits, including GLP-1 receptor agonists

Objectives for Pharmacy Technicians      

At the completion of this activity, the participant will be able to:

• List key recommendation updates to the 2024 AHA/ASA Primary Prevention of Stroke guidelines.
• Describe major changes in lifestyle modification advice (diet, exercise, smoking cessation, sleep, etc.) and risk factor screening (e.g., blood pressure, diabetes, cholesterol, social determinants of health) for stroke prevention
• Recite updates in pharmacologic management for stroke prevention, including use of antihypertensives, statins and newer lipid-lowering agents, diabetes medications (e.g., GLP-1 agonists), and antithrombotic therapy
• Discuss stroke prevention considerations in special populations, such as women (pregnancy, menopause, etc.) and transgender patients, as introduced in the 2024 guidelines
• List diabetes medications that now carry guideline-recommended cardiovascular and stroke risk reduction benefits, including GLP-1 receptor agonists

Accreditation:

Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

ACPE UAN:  0108-0000-25-057-L01-P; 0108-0000-25-057-L01-T

Activity type: Application-based

This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

Non-members will be charged $20.

To register: https://us06web.zoom.us/webinar/register/WN_HrRd2yKzRhC57wo06miT0A

VSHP Webinar 

Recording 

Tuesday, June 17, 2025 – 3:00pm-4:00 pm

Potentially Inappropriate Medication Use in Older Adults: Beers Criteria Updates

Speaker:

Madeline Johnson, Pharm.D.

PGY1 Pharmacy Resident 

HCA Healthcare | Chippenham & Johnston-Willis Hospital

Objectives for Pharmacists            

At the completion of this activity, the participant will be able to:

• Identify the purpose of Beers Criteria and the target audiences.
• Distinguish medication and criteria changes in the 2023 Beers Criteria update.
• Discuss evidence used to support changes made to recommendations in the 2023 Beers Criteria update.
• Formulate practical implementations of Beers Criteria recommendations in the clinical practice setting.

Objectives for Pharmacy Technicians      

At the completion of this activity, the participant will be able to:

• List the purpose of Beers Criteria and the target audiences.
• Recite medication and criteria changes in the 2023 Beers Criteria update.
• List evidence used to support changes made to recommendations in the 2023 Beers Criteria update.

Accreditation:

Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

ACPE UAN:  0108-0000-25-056-L01-P; 0108-0000-25-056-L01-T

Activity type: Application-based

This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

Non-members will be charged $20.

To register: https://us06web.zoom.us/webinar/register/WN_cnvBSER2SrSsodYVn0tVNg

VSHP Board will hold its annual Leadership Retreat June 27-28 at Wintergreen Resort.

The Board will use the time there conducting strategic planning and setting goals for VSHP's future.

Ballots for the election of VSHP Officers have been sent to all pharmacist members.   

Deadline to vote is 6/3/2025

VSHP Webinar 

Tuesday, May 27, 2025 – 12:00pm-1:00 pm

Dignity in Every Dose: Advocating for Thoughtful Deprescribing in Older Adults with Intellectual and Development Disabilities (IDD)

Speaker:

Jennifer Purdy, PharmD, BCGP, BCACP

Ambulatory Clinical Pharmacist, Geriatric Specialist

Riverside Health | Martha W. Goodson Center

Objectives for Pharmacists            

At the completion of this activity, the participant will be able to:

• Identify common medication-related risks in older adults with intellectual and developmental disabilities (IDD).
• Describe person-centered deprescribing principles that support autonomy, dignity, and individualized care in the IDD population.
• Apply evidence-based strategies and tools to evaluate and reduce potentially inappropriate medications in older adults with IDD.

Objectives for Pharmacy Technicians      

At the completion of this activity, the participant will be able to:

• Identify common medication-related risks in older adults with intellectual and developmental disabilities (IDD).
• Describe person-centered deprescribing principles that support autonomy, dignity, and individualized care in the IDD population.
• List evidence-based strategies and tools to evaluate and reduce potentially inappropriate medications in older adults with IDD.

Accreditation:

Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

ACPE UAN:  0108-0000-25-053-L01-P; 0108-0000-25-053-L01-T

Activity type: Application-based

This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

Non-members will be charged $20.

To register: https://us06web.zoom.us/webinar/register/WN_RtHOKbJDQhmangCXWPcTJg

VSHP Webinar 

Thursday, May 8, 2025 – 12:00pm-1:00 pm

The Fungus Among Us: Fungal Infections and Antifungal Therapy

If you missed it you can view the recording:  Webinars and Online CE

Speaker:

Olivia M Iannantuono, PharmD

PGY2 Pharmacy Resident

Children's Hospital of The King's Daughters

Objectives for Pharmacists            

At the completion of this activity, the participant will be able to:

• Recognize the difference between yeast, molds, and dimorphic fungi
• Review regional patterns of dimorphic fungi
• Identify clinical differences between various fungal infections 
• Discuss antifungal agents and their place in practice

Objectives for Pharmacy Technicians      

At the completion of this activity, the participant will be able to:

• Recite the difference between yeast, molds, and dimorphic fungi
• Review regional patterns of dimorphic fungi
• List clinical differences between various fungal infections 
• List antifungal agents and their place in practice

Accreditation:

Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

ACPE UAN:  0108-0000-25-052-L01-P; 0108-0000-25-052-L01-T

Activity type: Application-based

This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

Non-members will be charged $20.

To register: https://us06web.zoom.us/webinar/register/WN_wq54SDuST0myfwOY9wUgOg